Status:
UNKNOWN
Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effect of valsartan and perindopril on HOMA-IR Index in patients with chronic kidney disease.
Detailed Description
eligiable volunteers are administrated single-dose over the period I and II (crossover) of Valsartan (80mg) as of Perindopril (4mg). Every time before and after each medication, HOMA-IR index and oth...
Eligibility Criteria
Inclusion
- Clinical diagnosis of chronic kidney disease
- Serum creatinine:1\~3mg/dl
Exclusion
- Diabetes
- Patients treated with corticosteroids or immunosuppressants
- BMI\>30kg/m2
- SP\>180mmHg, DP\>110mmHg
- Patients with serious medical problems requiring specific medical treatment
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02299310
Start Date
November 1 2014
End Date
December 1 2015
Last Update
December 2 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853